PortfoliosLab logoPortfoliosLab logo
GILD vs. ORCL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GILD vs. ORCL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gilead Sciences, Inc. (GILD) and Oracle Corporation (ORCL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GILD achieves a 2.90% return, which is significantly higher than ORCL's -4.95% return. Over the past 10 years, GILD has underperformed ORCL with an annualized return of 7.84%, while ORCL has yielded a comparatively higher 18.60% annualized return.


GILD

1D
-0.22%
1M
-4.90%
YTD
2.90%
6M
5.60%
1Y
16.40%
3Y*
21.02%
5Y*
17.08%
10Y*
7.84%

ORCL

1D
0.02%
1M
-5.87%
YTD
-4.95%
6M
-2.48%
1Y
-13.59%
3Y*
17.80%
5Y*
18.90%
10Y*
18.60%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GILD vs. ORCL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GILD
Gilead Sciences, Inc.
2.90%36.59%18.68%-1.99%23.63%29.95%-6.70%7.88%-9.92%2.96%
ORCL
Oracle Corporation
-4.95%18.13%59.99%30.94%-4.65%36.89%24.25%19.34%-2.97%24.94%

Correlation

The correlation between GILD and ORCL is -0.10, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.00

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Jan 22, 1992

0.24

The correlation between GILD and ORCL shifts across timeframes, from -0.10 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

GILD:

$157.49B

ORCL:

$536.74B

EPS

GILD:

$7.35

ORCL:

$5.86

PE Ratio

GILD:

17.09

ORCL:

31.41

PEG Ratio

GILD:

0.04

ORCL:

1.29

PS Ratio

GILD:

5.30

ORCL:

7.97

PB Ratio

GILD:

6.70

ORCL:

12.47

Total Revenue (TTM)

GILD:

$29.74B

ORCL:

$67.36B

Gross Profit (TTM)

GILD:

$18.74B

ORCL:

$79.58B

EBITDA (TTM)

GILD:

$12.88B

ORCL:

$6.20B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GILD vs. ORCL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GILD
GILD Risk / Return Rank: 5959
Overall Rank
GILD Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
GILD Sortino Ratio Rank: 5757
Sortino Ratio Rank
GILD Omega Ratio Rank: 5454
Omega Ratio Rank
GILD Calmar Ratio Rank: 5858
Calmar Ratio Rank
GILD Martin Ratio Rank: 6262
Martin Ratio Rank

ORCL
ORCL Risk / Return Rank: 3939
Overall Rank
ORCL Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
ORCL Sortino Ratio Rank: 4040
Sortino Ratio Rank
ORCL Omega Ratio Rank: 3939
Omega Ratio Rank
ORCL Calmar Ratio Rank: 3939
Calmar Ratio Rank
ORCL Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GILD vs. ORCL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Oracle Corporation (ORCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GILDORCLDifference
Sharpe ratioReturn per unit of total volatility

+0.68

Sortino ratioReturn per unit of downside risk

+0.70

Omega ratioGain probability vs. loss probability

1.12

1.04

+0.08

Calmar ratioReturn relative to maximum drawdown

0.70

-0.12

+0.82

Martin ratioReturn relative to average drawdown

1.99

-0.20

+2.18

GILD vs. ORCL - Sharpe Ratio Comparison

The current GILD Sharpe Ratio is 0.57, which is higher than the ORCL Sharpe Ratio of -0.11. The chart below compares the historical Sharpe Ratios of GILD and ORCL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GILD vs. ORCL - Drawdown Comparison

The maximum GILD drawdown since its inception was -70.83%, smaller than the maximum ORCL drawdown of -84.19%. Use the drawdown chart below to compare losses from any high point for GILD and ORCL.


Loading charts...

Drawdown Indicators


GILDORCLDifference

Max Drawdown

Largest peak-to-trough decline

-70.83%

-84.19%

+13.36%

Max Drawdown (1Y)

Largest decline over 1 year

-21.59%

-58.25%

+36.66%

Max Drawdown (3Y)

Largest decline over 3 years

-26.59%

-58.25%

+31.66%

Max Drawdown (5Y)

Largest decline over 5 years

-26.59%

-58.25%

+31.66%

Max Drawdown (10Y)

Largest decline over 10 years

-30.47%

-58.25%

+27.78%

Current Drawdown

Current decline from peak

-18.93%

-43.48%

+24.55%

Average Drawdown

Average peak-to-trough decline

-22.15%

-29.11%

+6.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.61%

35.41%

-27.80%

Volatility

GILD vs. ORCL - Volatility Comparison

The current volatility for Gilead Sciences, Inc. (GILD) is 7.95%, while Oracle Corporation (ORCL) has a volatility of 23.44%. This indicates that GILD experiences smaller price fluctuations and is considered to be less risky than ORCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GILDORCLDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.95%

23.44%

-15.49%

Volatility (6M)

Calculated over the trailing 6-month period

19.02%

43.42%

-24.40%

Volatility (1Y)

Calculated over the trailing 1-year period

26.62%

65.91%

-39.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.12%

42.16%

-18.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.52%

35.12%

-9.60%

Dividends

GILD vs. ORCL - Dividend Comparison

GILD's dividend yield for the trailing twelve months is around 2.54%, more than ORCL's 1.09% yield.


PositionTTM20252024202320222021202020192018201720162015
GILD
Gilead Sciences, Inc.
1.91%2.57%3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%
ORCL
Oracle Corporation
1.09%0.97%0.96%1.44%1.57%1.38%1.48%1.72%1.68%1.52%1.56%1.56%

Financials

GILD vs. ORCL - Financials Comparison

This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Oracle Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


6.00B8.00B10.00B12.00B14.00B16.00B18.00B20.00B20222023202420252026
6.96B
19.18B
(GILD) Total Revenue
(ORCL) Total Revenue
Values in USD except per share items

Frequently Asked Questions


GILD and ORCL have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ORCL has higher volatility (23.44%) compared to GILD (7.95%). In terms of maximum drawdown, GILD dropped -70.83% vs ORCL's -84.19%.

GILD currently has the higher Sharpe Ratio (0.57 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GILD and ORCL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer